Deurali-Janta
Pharmaceuticals
© 2024 Deurali-Janta Pharmaceuticals
Silk Innovation
About Us
Executive Director's Message
Introduction
History
Mission
Vision
Business Scope
Qualification & Achievements
Nepal - Country Profile
Inside Deurali-Janta
MANUFACTURING
RESEARCH & DEVELOPMENT
QUALITY ASSURANCE
ENGINEERING
REGULATORY MANAGEMENT
MARKETING & SALES
MARKETING DIVISIONS
STORES
MARKET PLANNING
INTERNATIONAL BUSINESS
HUMAN RESOURCE
INFORMATION TECHNOLOGY (IT)
QUALITY & ENVIRONMENT POLICY
Products
Career
Why Deurali-Janta Pharmaceuticals
Explore Career/ Job Openings
Awareness Portal
HEALTH CARE
NUTRITION
GLOBAL RESEARCH
PHYSICAL FITNESS
TIPS & FACTS
CONDITIONS
News and Events
CSR
EDUCATION
HEALTH
SOCIAL WELFARE
CULTURE
ENVIRONMENT
Covid 19
Contact Us
PRODUCTS
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Salbutamol Sulfate equivalent to Salbutamol 2 mg + Bromhexine HCl 4 mg per 5ml in 100 ml
Salbutamol Sulfate equivalent to Salbutamol 2 mg per 5 ml in 100 ml
Salicylic acid 20% w/w in 15 g
Salicylic acid 40% w/w in 15 g
Secnidazole 1000 mg
Serratiopeptidase 10 mg enteric coated
Serratiopeptidase 5 mg enteric coated
Silver Sulfadiazine 1.0% w/w & Chlorhexidine Gluconate 0.2% w/w in 30 g and 250 g
Sitagliptin 100 mg
Sitagliptin 50 mg
Spores of Bacillus clausii 2 Billion CFU Capsule
Sucralfate 500 mg/5 ml Suspension (180 ml)
Sulfasalazine 500 mg
